Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin
This study has been completed.
Dr. Philipp Zanger, MD MSc DTM
Information provided by (Responsible Party):
Dr. Philipp Zanger, MD MSc DTM, University Hospital Tuebingen
First received: September 16, 2009
Last updated: November 7, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2012|
|Primary Completion Date:||March 2012 (Final data collection date for primary outcome measure)|
Zanger P, Nurjadi D, Gabor J, Gaile M, Kremsner PG. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Infect Dis. 2013 Nov;13(11):946-54. doi: 10.1016/S1473-3099(13)70221-4.